For the reduction of atherosclerotic events (myocardial infarction, stroke or vascular death) in patients with atherosclerosis documented by recent stroke, myocardial infarction, or established peripheral arterial disease. For the treatment of patients suffering from non-ST segment elevation, acute coronary syndrome (unstable angina or non-Q wave myocardial infarction) including patient undergoing stent placement following percutaneous coronary intervention or combination with ASA in medically treated patients eligible from thrombolytic therapy.
Sign Out
